Description
Product details
Actorise Injection is a prescription darbepoetin alfa injection available in multiple strengths, including Actorise 25, Actorise 100 and Actorise 200. These products belong to the erythropoiesis-stimulating agent (ESA) class of medicines and are used under medical supervision for the management of anemia associated with conditions such as chronic kidney disease (CKD) and certain cases of chemotherapy-induced anemia. Darbepoetin alfa supports the body's red blood cell production by stimulating the bone marrow. Treatment is individualized according to the patient's hemoglobin level, clinical condition and response to therapy. Available Actorise Variants Actorise 25 Injection Darbepoetin Alfa 25 mcg Actorise 100 Injection Darbepoetin Alfa 100 mcg Actorise 200 Injection Darbepoetin Alfa 200 mcg *The linked listings call these “mg,” but darbepoetin alfa products are generally labeled in mcg. Confirm the exact strength and volume from each physical pack before publishing. Clinical Uses Chronic Kidney Disease–Associated Anemia Reduced kidney function can result in insufficient erythropoietin production and consequently lower red blood cell levels. Darbepoetin alfa may be prescribed to stimulate erythropoiesis and help manage anemia associated with chronic kidney disease. Chemotherapy-Associated Anemia Some chemotherapy regimens can suppress red blood cell production. In appropriately selected patients, Actorise may be prescribed as an ESA therapy for chemotherapy-related anemia to support red blood cell and hemoglobin levels. How Actorise Works Darbepoetin alfa acts similarly to naturally occurring erythropoietin and stimulates erythropoietin receptors in the bone marrow. This encourages the formation of red blood cells and helps improve hemoglobin levels over time. Administration & Monitoring Actorise is administered according to the physician's prescribed dose and schedule. Depending on the specific product and clinical indication, darbepoetin alfa may be administered subcutaneously or intravenously. During therapy, healthcare professionals may monitor hemoglobin, blood pressure, complete blood count and iron status. Dose adjustments should only be made by the treating physician. Possible Side Effects Potential adverse effects can include high blood pressure, headache, injection-site reactions and hypersensitivity reactions. Darbepoetin alfa also carries clinically important cardiovascular and thromboembolic risks, so appropriate patient selection and monitoring are essential.
